KAINOS MEDICINE, INC. Logo

KAINOS MEDICINE, INC.

Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.

284620 | KO

Overview

Corporate Details

ISIN(s):
KR7284620002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 코리아바이오파크 제3층 제에이-301호 일부, 성남시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kainos Medicine, Inc. is a clinical-stage research and development company specializing in the discovery of innovative medicines. The firm's primary focus is on developing novel small molecule therapeutics to address unmet medical needs in neurodegenerative disorders, cancers, and infectious diseases. Its drug pipeline includes candidates for the treatment of conditions such as Parkinson's disease, multiple system atrophy (MSA), and AIDS. The company advances its portfolio through both independent research and strategic collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (다계통 위축증(MSA) 치료신약 KM-819의 임상 2상 …
Korean 26.9 KB
2025-09-05 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.3 MB
2025-09-05 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 1.4 MB
2025-09-05 00:00
Regulatory News Service
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
Korean 3.2 KB
2025-09-03 00:00
Earnings Release
[기재정정]반기또는분기매출액미달사실발생
Korean 14.3 KB
2025-09-01 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-08-18 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Korean 3.0 KB
2025-08-18 00:00
Audit Report / Information
[기재정정]반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 16.6 KB
2025-08-18 00:00
Regulatory News Service
불성실공시법인지정 (공시변경)
Korean 5.6 KB
2025-08-14 00:00
Delisting Announcement
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Korean 4.6 KB
2025-08-14 00:00
Earnings Release
반기또는분기매출액미달사실발생
Korean 9.4 KB
2025-08-14 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 관련)
Korean 2.9 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.8 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB

Automate Your Workflow. Get a real-time feed of all KAINOS MEDICINE, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAINOS MEDICINE, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAINOS MEDICINE, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Xenetic Biosciences, Inc. Logo
Advancing DNase & CAR T immune-oncology platforms to treat hard-to-treat cancers.
United States of America
XBIO
Xilio Therapeutics, Inc. Logo
Engineering tumor-activated biologics for cancer to maximize efficacy and minimize toxicity.
United States of America
XLO
XLMEDIA PLC Logo
A former performance marketing company for the sports and gaming industries.
Jersey
XLM
XORTX Therapeutics Inc. Logo
Developing late-stage, uric acid-lowering therapies for gout and progressive kidney disease.
United States of America
XRTX
Xplus Inc. Logo
IT consultancy guiding digital transformation via enterprise architecture & program management.
South Korea
373200
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage drugs for unmet medical needs, focusing on autoimmune diseases.
Israel
XTLB
YAMADA Consulting Group  CO.,LTD. Logo
Japanese consulting firm offering global M&A, strategy, and financial advisory services.
Japan
4792
Y-Biologics, Inc Logo
Develops novel antibody cancer therapies using proprietary T-cell engager & antibody library tech.
South Korea
338840
Yellow Balloon Tour Co., Ltd. Logo
Offers domestic & international travel packages, flights, and tours for individuals and groups.
South Korea
104620
Yoshimura Food Holdings K.K. Logo
Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.
Japan
2884

Talk to a Data Expert

Have a question? We'll get back to you promptly.